06/11/2026
We're thrilled to announce our selection for the build-out of Akebia Therapeutics' new headquarters in Waltham.
The updated 43,000 SF of office space and laboratory facilities will support Akebia's continued growth and innovation in developing therapies for people living with kidney disease and other serious conditions.
We look forward to delivering this phased project alongside BXP, Inc. and Stantec.
Read more about the project: https://www.chap-con.com/chapman-gets-43000-sf-office-build-out-at-bxps-citypoint-for-akebia-hq
We are excited to announce that we have been selected to provide construction services for Akebia Therapeutics’ new headquarters in Waltham, Massachusetts. Akebia, relocating from Cambridge in the Fall of 2026, is recognized for developing and commercializing therapies for people living with kidne...